These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2024654)

  • 41. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection.
    Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473
    [No Abstract]   [Full Text] [Related]  

  • 42. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
    Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
    Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum potassium concentrations in cyclosporine- and azathioprine-treated renal transplant patients.
    Foley RJ; Hamner RW; Weinman EJ
    Nephron; 1985; 40(3):280-5. PubMed ID: 3892345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Macroangiopathy of a kidney graft caused by cyclosporin A].
    Jurine N; Guérin C; Kalil C; Broyet C; Veyret C; Berthoux F
    Ann Radiol (Paris); 1989; 32(2):147-9. PubMed ID: 2667434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients.
    van den Dorpel MA; Ghanem H; Rischen-Vos J; Man in't Veld AJ; Jansen H; Weimar W
    Kidney Int; 1997 May; 51(5):1608-12. PubMed ID: 9150480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conversion from cyclosporine to azathioprine in renal allograft recipients.
    Rocher LL; Milford EL; Kirkman RL; Carpenter CB; Strom TB; Tilney NL
    Transplantation; 1984 Dec; 38(6):669-74. PubMed ID: 6390830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.
    Young BA; Marsh CL; Alpers CE; Davis CL
    Am J Kidney Dis; 1996 Oct; 28(4):561-71. PubMed ID: 8840947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
    Gruber SA; Pescovitz MD; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Fryd DS
    Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study.
    Novick AC; Hwei HH; Steinmuller D; Streem SB; Cunningham RJ; Steinhilber D; Goormastic M; Buszta C
    Transplantation; 1986 Aug; 42(2):154-8. PubMed ID: 3526655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients.
    Lorber MI; Van Buren CT; Flechner SM; Williams C; Kahan BD
    Transplantation; 1987 Jan; 43(1):35-40. PubMed ID: 3541320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
    Milford EL; Kirkman RL; Tilney NL; Strom TB; Carpenter CB
    Am J Kidney Dis; 1985 Jun; 5(6):313-7. PubMed ID: 3925762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
    Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
    Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants.
    Gordon RD; Iwatsuki S; Shaw BW; Starzl TE
    Am J Kidney Dis; 1985 Jun; 5(6):307-12. PubMed ID: 3893105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postoperative deep venous thrombosis after renal transplantation. Effects of cyclosporine.
    Brunkwall J; Bergqvist D; Bergentz SE; Bornmyr S; Husberg B
    Transplantation; 1987 May; 43(5):647-9. PubMed ID: 3554656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 60. Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
    Langer RM; Kahan BD
    Transplantation; 2003 Jul; 76(2):318-23. PubMed ID: 12883185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.